Becker, Katja
Banaschewski, Tobias
Brandeis, Daniel
Dose, Christina
Hautmann, Christopher
Holtmann, Martin
Jans, Thomas
Jendreizik, Lea
Jenkner, Carolin
John, Katja
Ketter, Johanna
Millenet, Sabina
Pauli-Pott, Ursula
Renner, Tobias
Romanos, Marcel
Treier, Anne-Katrin
von Wirth, Elena
Wermter, Anne-Kathrin
Döpfner, Manfred
Funding for this research was provided by:
BMBF (Grant 01EE1408)
Article History
Received: 14 August 2019
Accepted: 31 October 2019
First Online: 9 January 2020
Ethics approval and consent to participate
: The ESCApreschool study has been approved by the Ethics Committee of the Medical Faculty of the Phillips University of Marburg, Germany (No. 87/15). Additionally, it has been approved by all local Ethics Committees of the participating centres in Germany: Faculty of Medicine of the Ruhr-University Bochum (No. 15–5523), the Medical Faculty of the University of Cologne (No. 15–335), the Ethics Committee of the State Chamber of Medicine (Landesärztekammer) Baden-Württemberg (No. B-F-2015-080), the Medical Faculty of the University of Würzburg (No. 254/15_z), the Faculty of Medicine of the Eberhard Karls University Tübingen (No. 728/2015BO2), the Medical Faculty of the University Aachen (No. EK 204/17), the Medical Faculty of the University Göttingen (No. 4/3/17) and the Brandenburg Medical School Theodor Fontane.In order to participate in the study, both parents/guardians are informed about the study procedures and goals and give their written informed consent. The preschool child has additionally to give his/her assent for participation.
: Not applicable.
: KB has been involved in research/clinical trials with Eli Lilly (≤ 2011) and Shire (≤ 2010), was on the Advisory Board of Eli Lilly/Germany (≤ 2014), a member of the Scientific Committee of Shire (≤ 2012) and was paid for public speaking by Eli Lilly (< 2011) and Shire (2015). These activities do not bias the objectivity of this manuscript (in her opinion), but are mentioned for the sake of completeness.TB served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire, and Infectopharm. He received conference support or speaker’s fees from Lilly, Medice, and Shire. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press.DB served as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work.CD and MD were involved in the development of the materials used in the TASH intervention and will receive royalties after publication of the materials.MH served in an advisory or consultancy role for Lilly, Shire, and Medice, and received conference attendance support or was paid for public speaking by Medice, Neuroconn, and Shire.MD received consulting income and research support from Lilly, Medice, Shire, Janssen Cilag, Novartis, and Vifor. He received income as Head of the School for Child and Adolescent Behaviour Therapy at the University of Cologne and royalties from treatment manuals, books and psychological tests published by Guilford, Hogrefe, Enke, Beltz, and Huber, including the materials used in the PMPTT intervention.CH, TJ, LJ, CJ, KJ, JK, SM, UPP, TR, MR, AKT, EvW, and AKW are not aware of any biases that might be perceived as affecting the objectivity of this manuscript and declare that they have no competing interests.